Inhalation Sciences Sweden AB Stock OTC Markets
Stocks
INHSF
SE0009983893
Advanced Medical Equipment & Technology
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| - USD | -.--% |
|
-.--% | - |
| 07-29 | Inhalation Sciences secures financing of up to €0.4m | FW |
| 06-16 | Inhalation Sciences Secures SEK 0.4m Research Grant | FW |
| Market Cap | 9.47M 998K 865K 806K 741K 1.4M 94.93M 1.42M 3.72M 47.5M 3.75M 3.67M 157M | P/E 2024 |
-12.8x | P/E 2025 | -12.4x |
|---|---|---|---|---|---|
| Enterprise Value | 6.64M 700K 606K 565K 520K 981K 66.55M 992K 2.61M 33.3M 2.63M 2.57M 110M | EV / Sales 2024 |
5.6x | EV / Sales 2025 | 55x |
| Free-Float |
94.25% | Yield 2024 * |
-
| Yield 2025 | - |
| Manager | Title | Age | Since |
|---|---|---|---|
Manoush Masarrat
CEO | Chief Executive Officer | - | 16/09/2019 |
Per Magnus Gerde
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/2005 |
Ulf Wedenberg
PRN | Corporate Officer/Principal | - | 02/06/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Per Magnus Gerde
BRD | Director/Board Member | - | 01/01/2005 |
Jan Hellqvist
BRD | Director/Board Member | - | 01/09/2022 |
Ulf Ericsson
BRD | Director/Board Member | - | 01/09/2024 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 992K | |
| +2.32% | +0.24% | +23.89% | +4.72% | 209B | |
| +2.51% | +1.61% | +0.31% | -21.89% | 137B | |
| +1.88% | +6.26% | -21.34% | +21.33% | 130B | |
| -2.75% | +3.69% | -54.46% | -5.89% | 71.14B | |
| -0.70% | +3.74% | +12.28% | +11.44% | 51.59B | |
| +0.62% | +9.24% | -15.14% | -20.39% | 49.99B | |
| +1.37% | +0.58% | +22.82% | +11.54% | 39.31B | |
| +0.99% | +5.41% | +42.25% | +38.06% | 38.89B | |
| +0.40% | +4.55% | -21.39% | +20.01% | 32.19B | |
| Average | +0.82% | +3.19% | -1.20% | +6.55% | 84.33B | |
| Weighted average by Cap. | +1.41% | +1.42% | +0.14% | +3.28% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 11.05M 1.16M 1.01M 940K 865K 1.63M 111M 1.65M 4.34M 55.4M 4.37M 4.28M 183M | 3.04M 321K 278K 259K 238K 449K 30.48M 454K 1.19M 15.25M 1.2M 1.18M 50.51M |
| Net income | -5.15M -543K -470K -438K -403K -761K -51.59M -769K -2.02M -25.81M -2.04M -1.99M -85.48M | -10.16M -1.07M -927K -865K -795K -1.5M -102M -1.52M -3.99M -50.95M -4.02M -3.93M -169M |
| Net Debt | -4M -422K -365K -341K -313K -591K -40.12M -598K -1.57M -20.07M -1.58M -1.55M -66.48M | -2.83M -298K -258K -241K -222K -418K -28.37M -423K -1.11M -14.2M -1.12M -1.1M -47.02M |
Employees
5
Calendar
Net sales - Rate of surprise
- Stock Market
- Stocks
- ISAB Stock
- INHSF Stock
Select your edition
All financial news and data tailored to specific country editions
